Literature DB >> 11377443

Relevance of the site of injury of glaucoma to neuroprotective strategies.

L A Levin1.   

Abstract

Glaucomatous optic neuropathy is a chronic progressive disease associated with characteristic changes in the morphology of the optic disk, pattern of visual field, and death of retinal ganglion cells. Neuroprotection is a potential treatment for glaucomatous optic neuropathy which acts independently of lowering intraocular pressure. Neuroprotective strategies differ in their site of action, and it is important to correlate this with the location at which the glaucomatous injury occurs. This article describes a hypothetical scheme for determining the site of progression of glaucomatous optic neuropathy and discusses the implications of this model for evaluating studies of neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377443     DOI: 10.1016/s0039-6257(01)00197-7

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  7 in total

Review 1.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

2.  Superoxide generation explains common features of optic neuropathies associated with cecocentral scotomas.

Authors:  Leonard A Levin
Journal:  J Neuroophthalmol       Date:  2015-06       Impact factor: 3.042

3.  Intracellular disulfide reduction by phosphine-borane complexes: Mechanism of action for neuroprotection.

Authors:  Nicholas J Niemuth; Alex F Thompson; Megan E Crowe; Christopher J Lieven; Leonard A Levin
Journal:  Neurochem Int       Date:  2016-06-02       Impact factor: 3.921

Review 4.  Neuroprotection for glaucoma: Requirements for clinical translation.

Authors:  Leonard A Levin; Megan E Crowe; Harry A Quigley
Journal:  Exp Eye Res       Date:  2016-12-09       Impact factor: 3.467

5.  The sigma receptor ligand (+)-pentazocine prevents apoptotic retinal ganglion cell death induced in vitro by homocysteine and glutamate.

Authors:  Pamela Moore Martin; Mohammad S Ola; Neeraj Agarwal; Vadivel Ganapathy; Sylvia B Smith
Journal:  Brain Res Mol Brain Res       Date:  2004-04-07

Review 6.  Neuroprotection in glaucoma.

Authors:  Sushil K Vasudevan; Viney Gupta; Jonathan G Crowston
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848

Review 7.  Intrinsically photosensitive retinal ganglion cells in glaucoma.

Authors:  Jingyi Gao; Ignacio Provencio; Xiaorong Liu
Journal:  Front Cell Neurosci       Date:  2022-09-23       Impact factor: 6.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.